Biotech Cyclacel Pharmaceuticals Achieves Key Business Objectives in First Half of 2022 and Continues to Advance Clinical Pipeline June 30, 2022
Biotech Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO June 30, 2022
Biotech Daré Bioscience Announces Closing of Global License Agreement with Organon to Commercialize XACIATO(TM) (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis June 30, 2022
Biotech Bragar Eagel & Squire, P.C. Is Investigating Agrify, Carvana, Enochian, and Corcept and Encourages Investors to Contact the Firm June 29, 2022